Dual-isotope imaging: reduced-dose, shorter-scan-time stress images acquired with 20 mCi Tc-99m at 10 sec/frame. Photo courtesy of Mayo Clinic.

Dual-isotope imaging: reduced-dose, shorter-scan-time stress images acquired with 20 mCi Tc-99m at 10 sec/frame. Photo courtesy of Mayo Clinic.


March 9, 2010 – As an alternative to the technetium (Tc-99M) isotope used in many nuclear imaging studies, UltraSPECT is advocating the use of thallium isotope (TI-201) imaging as an alternative. Due to the impact of the Canadian reactor shutdown combined with the recently announced six-month repair plan of the Dutch reactor, the global shortage of Tc-99m is expected to remain grave in the next few months, leaving nuclear medicine in a precarious position. The shortage means there is an inability to provide patients with needed tests, longer delays in exam scheduling, use of reduced-dose imaging protocols, and loss of business to other imaging modalities such as CTA, echo and cardiac PET. The company offers two cardiac products, Xpress.Cardiac and Xpert3.Cardiac, which support Tl-201 imaging. These products utilize UltraSPECT's proprietary WBR image reconstruction capabilities to enable reduced-dose and enhanced-resolution thallium imaging. The products allow the utilization of lower dose imaging protocols using Tc-99m with no compromise in terms of imaging acquisition times and diagnostic value. They also support reduced-dose and enhanced-resolution Tl-201 imaging, helping alleviating the impact of the technetium shortage while reducing patient radiation exposure. UltraSPECT products feature connectivity to the imaging systems of all three major nuclear medicine camera manufacturers. “UltraSPECT has allowed us to acquire high-quality gated SPECT images with Tl-201, without increasing scan times,” said John Zeitz, M.D., chief of nuclear medicine at Beaumont Hospital in Troy, Mich. “Previously, we would have to increase our imaging time by 50 percent in order to achieve decent image quality for the gated cine reconstruction." The one-day dual-isotope (Tl-201 and Tc-99m) protocol performed with the Xpress3.Cardiac combines reduced doses with shorter scan times. Reduced-dose, shorter-scan-time rest Tl-201 imaging is followed by reduced-dose, shorter-scan-time Tc-99m stress imaging, rendering the procedure safer and more comfortable for the patient, while ensuring sustained/increased patient throughput for the practice: • Rest: Tl-201, 2 mCi (female) / 3 mCi (male); 20sec. per stop. • Stress: Tc-99m, 20 mCi (female) / 30 mCi (male); 10sec. per stop. UltraSPECT’s Xpress.Cardiac, Xpress3.Cardiac, and Xpress/Xact.BoneTM products are distributed in the USA exclusively by Cardinal Health. UltraSPECT products are distributed in the USA by Cardinal Health (www.cardinalhealth.com). For more information: www.ultraspect.com

 


Related Content

News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
News | SPECT Imaging

February 15, 2024 — According to a release issued by the U.S. Food and Drug Administration (FDA), Philips is recalling ...

Time February 15, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 14, 2024 — PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of ...

Time February 14, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | PET Imaging

February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before ...

Time February 09, 2024
arrow
News | Interventional Radiology

February 6, 2024 — RenovoRx, Inc., a clinical-stage biopharmaceutical company developing novel precision oncology ...

Time February 06, 2024
arrow
News | SNMMI

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
arrow
Subscribe Now